Some investigators [16,18,21] have examined the relationship between variants of the LEPR Gln223Arg polymorphism and serum levels of leptin since there is some evidence associating serum leptin levels with breast cancer risk [17,18]. The gene discussed is LEP; the disease is breast carcinoma.